This website is intended for healthcare professionals only

Trending Topic

31 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Ventricular fibrillation (VF) is characterized by rapid (>300 beats a per minute), irregular electrical activation with variable electrocardiographic waveforms that prevents coordinated myocardial contraction, resulting in immediate loss of cardiac output.1 It most commonly occurs in the context of coronary artery disease.2,3 Resuscitation efforts are critically time-dependent: with each minute of untreated VF, the survival rate declines […]

Artur Fedorowski, EHRA 2021: What’s new in Syncope?

Artur Fedorowski
6.04
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 25th 2021

Dr Artur Fedorowski (Associate Professor of Cardiovascular Research, Lund University, Lund, Sweden) gave us an update on what’s new in Syncope, from the European Heart Rhythm Association (EHRA) Virtual Meeting 2021.

Questions:

  1. How can we reduce the heterogeneity of syncope diagnosis and management across Europe? (0:21)
  2. Could you tell us a little about recent advances in our understanding of neuroendocrine changes in vasovagal syncope, and their implications for optimal clinical management? (1:19)
  3. What have been the most promising recent advances in the clinical management of vasovagal syncope? (2:43)
  4. What is your opinion of the potential role of permanent pacing in the clinical management of vasovagal syncope? (4:29)

Speaker disclosures: Prof. Artur Fedorowski has received Speaker Fees from Medtronic Inc, Biotronik, and Finapres Medicals.

Interview and filming supported by Touch Medical Media. Interview conducted by Louise Taylor.

Filmed during a remote video call with Prof. Artur Fedorowski as a highlight of EHRA 2021, May 2021

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup